Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 106, Issue 3, 2014, Pages 465-473

  Sanke, Haruna ^a   Mita, Tomoya ^a   Yoshii, Hidenori ^b   Yokota, Ayako ^b   Yamashiro, Keiko ^b   Ingaki, Noriko ^b   Onuma, Tomio ^b   Someya, Yuki ^a   Komiya, Koji ^a   Tamura, Yoshifumi ^a   Shimizu, Tomoaki ^a   Ohmura, Chie ^a   Kanazawa, Akio ^a   Fujitani, Yoshio ^a   Watada, Hirotaka ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

Author keywords

Cognitive impairment; Elderly patients; Olfactory function; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FOLIC ACID; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

AGE; AGE DISTRIBUTION; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SENSORY SYSTEM EXAMINATION; SMELLING DISORDER; URIC ACID URINE LEVEL; URINARY EXCRETION; CLINICAL TRIAL; COGNITION; COGNITION DISORDERS; COMPLICATION; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; ODOR; OLFACTION DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; OLFACTION DISORDERS; RETROSPECTIVE STUDIES; SMELL;

EID: 84920680762     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.09.039     Document Type: Article

References (39)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-53.
2. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
3. Feil D.G., Pearman A., Victor T., Harwood D., Weinreb J., Kahle K., et al. The role of cognitive impairment and caregiver support in diabetes management of older outpatients. Int J Psychiatry Med 2009, 39:199-214.
4. Rosen C.S., Chow H.C., Greenbaum M.A., Finney J.F., Moos R.H., Sheikh J.I., et al. How well are clinicians following dementia practice guidelines. Alzheimer Dis Assoc Disord 2002, 16:15-23.
5. Serby M., Larson P., Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 1991, 148:357-360.
6. Mesholam R.I., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998, 55:84-90.
7. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K., et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000, 157:1399-1405.
8. Murphy C., Bacon A.W., Bondi M.W., Salmon D.P. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci 1998, 855:744-750.
9. Schiffman S.S., Graham B.G., Sattely-Miller E.A., Zervakis J., Welsh-Bohmer K. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiol Aging 2002, 23:397-404.
10. Schubert C.R., Carmichael L.L., Murphy C., Klein B.E., Klein R., Cruickshanks K.J. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc 2008, 56:1517-1521.
11. Wilson R.S., Arnold S.E., Tang Y., Bennett D.A. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 2006, 26:61-67.
12. Le Floch J.P., Le Lievre G., Labroue M., Paul M., Peynegre R., Perlemuter L. Smell dysfunction and related factors in diabetic patients. Diabetes Care 1993, 16:934-937.
13. Forsell Y., Fratiglioni L., Grut M., Viitanen M., Winblad B. Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand 1992, 86:49-54.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975, 12:189-198.
15. Crum R.M., Anthony J.C., Bassett S.S., Folstein M.F. Population-based norms for the mini-mental state examination by age and educational level. J Am Med Assoc 1993, 269:2386-2391.
16. Anstey K.J., Burns R.A., Birrell C.L., Steel D., Kiely K.M., Luszcz M.A. Estimates of probable dementia prevalence from population-based surveys compared with dementia prevalence estimates based on meta-analyses. BMC Neurol 2010, 10:62.
17. Makizako M., Makizako H., Doi T., Uemura K., Tsutsumimoto K., Miyaguchi H., et al. Olfactory identification and cognitive performance in community-dwelling older adults with mild cognitive impairment. Chem Senses 2014, 39:39-46.
18. Fujio H., Doi K., Hasegawa S., Kobayakawa T., Nibu K. Evaluation of card-type odor identification test for Japanese patients with olfactory disturbance. Ann Otol, Rhinol, Laryngol 2012, 121:413-418.
19. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
20. Ebady S.A., Arami M.A., Shafigh M.H. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract 2008, 82:305-309.
21. Yamazaki Y., Miwa T., Sakurai H., Hanyu H., Iwamoto T., Odawara M. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J 2011, 58:109-115.
22. Umegaki H., Hayashi T., Nomura H., Yanagawa M., Nonogaki Z., Nakshima H., et al. Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly. Geriatr Gerontol Int 2013, 13:28-34.
23. Haan M.N., Weldon M. The influence of diabetes, hypertension, and stroke on ethnic differences in physical and cognitive functioning in an ethnically diverse older population. Ann Epidemiol 1996, 6:392-398.
24. Bruce D.G., Davis W.A., Casey G.P., Starkstein S.E., Clarnette R.M., Foster J.K., et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008, 51:241-248.
25. Umegaki H., Iimuro S., Shinozaki T., Araki A., Sakurai T., Iijima K., et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 2012, 12(1):103-109.
26. Marioni R.E., Strachan M.W., Reynolds R.M., Lowe G.D., Mitchell R.J., Fowkes F.G., et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010, 59:710-713.
27. Une K., Takei Y.A., Tomita N., Asamura T., Ohrui T., Furukawa K., et al. Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur J Neurol: Off J Eur Fed Neurol Soc 2011, 18:1006-1009.
28. Patterson D.S., Turner P., Smart J.V. Smell threshold in diabetes mellitus. Nature 1966, 209:625.
29. Sharma R., Buras E., Terashima T., Serrano F., Massaad C.A., Hu L., et al. Hyperglycemia induces oxidative stress and impairs axonal transport rates in mice. PloS One 2010, 5:e13463.
30. Marks D.R., Tucker K., Cavallin M.A., Mast T.G., Fadool D.A. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci: Off J Soc Neurosci 2009, 29:6734-6751.
31. Aime P., Hegoburu C., Jaillard T., Degletagne C., Garcia S., Messaoudi B., et al. A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. PloS One 2012, 7:e51227.
32. Weinstock R.S., Wright H.N., Smith D.U. Olfactory dysfunction in diabetes mellitus. Physiol Behav 1993, 53:17-21.
33. Eibenstein A., Fioretti A.B., Lena C., Rosati N., Amabile G., Fusetti M. Modern psychophysical tests to assess olfactory function. Neurol Sci: Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 2005, 26:147-155.
34. Sohrabi H.R., Bates K.A., Rodrigues M., Taddei K., Laws S.M., Lautenschlager N.T., et al. Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. J Alzheimer's Dis 2009, 17:135-142.
35. Swan G.E., Carmelli D. Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002, 21:58-67.
36. Lojkowska W., Sawicka B., Gugala M., Sienkiewicz-Jarosz H., Bochynska A., Scinska A., et al. Follow-up study of olfactory deficits, cognitive functions, and volume loss of medial temporal lobe structures in patients with mild cognitive impairment. Curr Alzheimer Res 2011, 8:689-698.
37. Riedel G., Micheau J. Function of the hippocampus in memory formation: desperately seeking resolution. Prog Neuro-psychopharmacol Biol Psychiatry 2001, 25:835-853.
38. Wilson R.S., Arnold S.E., Schneider J.A., Tang Y., Bennett D.A. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol, Neurosurg, Psychiatry 2007, 78:30-35.
39. Cerf-Ducastel B., Murphy C. Neural substrates of cross-modal olfactory recognition memory: An fMRI study. Neuroimage 2006, 31:386-396.